Health Companies To Hire More Cyber Experts In 2022, Telehealth Hikes Vulnerabilities

The number of health care employees dedicated to cybersecurity is projected to increase significantly in 2022, with cyber-related employment in hospitals, pharmaceutical companies, and medical device communities projected to grow more than it did in 2021, according to a report from Moody’s Investors Service. The increasing use of telehealth technology during the COVID-19 pandemic, Moody’s notes, has created additional vulnerabilities for health systems. “We expect cyber risk to remain especially high for hospitals. The large amount of sensitive patient...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Topics: 

As WTO Members Eye Expanding TRIPS Decision, U.S. Treads Carefully

As lawmakers and industry groups increase pressure against the push at the World Trade Organization to expand a recent intellectual property decision to include diagnostics and therapeutics, the Biden administration has kept a low profile, declining to say publicly where it stands -- but its past positions and a recent statement suggest no eagerness to move forward on the issue. WTO members during the 12th ministerial conference last month agreed to further flexibilities under the Agreement on Trade-Related Aspects of...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 08/05/2022
FDA Volume: 
Vol. 28, No. 31
Author: 








CDC Makes Monkeypox Treatment Available Via Telehealth

The Centers for Disease Control and Prevention and FDA have unveiled a streamlined process for health care providers to offer a smallpox antiviral treatment to patients who have monkeypox, which includes the option to prescribe the drug via telehealth. CDC is using an Investigational New Drug expanded access flexibility that “allows for the use of tecovirimat for primary or early empiric treatment of non-variola orthopoxvirus infections, including monkeypox, in adults and children of all ages,” according to a new update...
Article Type: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 07/29/2022
FDA Volume: 
Vol. 28, No. 30
Author: 

Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.